Stock Price Quote

ANG LIFESCIENCES INDIA LTD.

NSE : NABSE : 540694ISIN CODE : INE236W01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE30.000 (0 %)
PREV CLOSE ( ) 30.00
OPEN PRICE ( ) 30.00
BID PRICE (QTY) 30.15 (1)
OFFER PRICE (QTY) 30.10 (3300)
VOLUME 909
TODAY'S LOW / HIGH ( )30.00 30.00
52 WK LOW / HIGH ( ) 21.0362.75
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 14-06 2006
Management Info
- Chairman Rajesh Gupta - Managing Director
Registered Office

Address Darbara Complex, Sco 113, First Floor,District Shopping Centre,B Block Ranjit Avenue,
Amritsar,
Punjab-143001

Phone 0183 5133455 / 5133473

Email operations@anglifesciences.com

Website www.anglifesciences.com

Registrars Details
Bigshare Services Pvt Ltd
E-2/3, Ansa Industrial Estate,Saki Vihar Road,Saki Naka,Mumbai
Listing : BSE

NEWS

24Apr ANG Lifesciences informs about not app
With reference to the SEBI Circular -SEBI/HO/DDHS/CIR/P/2018/144 dated 2..
25Sep ANG Lifesciences India informs about t
ANG Lifesciences India has informed that the trading window for dealing..
29Jun ANG Lifesciences India informs about c
ANG Lifesciences India has informed that pursuant to SEBI (Prohibition o..
17Feb ANG Lifesciences India informs about n
Pursuant to Regulation 30 & 47 of SEBI (Listing Obligation and Discl..
28Mar DLF, Manappuram Finance and Crompton G
DLF is planning to invest around Rs 2,000 crore to construct two new sho..

Financials

in Millions
QTR Mar 25 ANNUAL 25
Net Profit-19.4-103.44
Gross Profit -29.6 -129.38
Operating Profit 3.890000000000016.36000000000001
Net Sales 176.66899.1

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE)
peergroup  10380.05 (1.98%)
M.Cap ( in Cr)25407.00
RPG Life Sciences (BSE)
peergroup  2344.95 (4.31%)
M.Cap ( in Cr)3769.24
Concord Biotech (BSE)
peergroup  2115.15 (2.66%)
M.Cap ( in Cr)21332.29
Mercury Laboratories (BSE)
peergroup  889.00 (6.12%)
M.Cap ( in Cr)100.53
Fredun Pharma (BSE)
peergroup  831.00 (3.95%)
M.Cap ( in Cr)383.85

Shareholding Pattern

PROMOTERS 70.6%
NON-INSTITUTION 29.4%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About ANG Lifesciences India Ltd.

ANG Lifesciences India Ltd. was incorporated in the year 2006. Its today's share price is 30. Its current market capitalisation stands at Rs 39.17 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1313.69 Cr and Total Income of Rs.1322.04 Cr. The company's management includes Harshita Aggarwal, Chetna, Harvinder Singh, Sukhpal Singh, Rohit Mittal, Saruchi Gupta, Rajesh Gupta.

It is listed on the BSE with a BSE Code of 540694 , NSE with an NSE Symbol of and ISIN of INE236W01016. It's Registered office is at Darbara Complex, Sco 113, First Floor,District Shopping Centre,B Block Ranjit AvenueAmritsar-143001, Punjab. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Ajay K Khanna & Co, Raman Wadhwa & Co, Singh Bhupinder & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.